Project Grant K01TW013200
Award Date 9/22/25
Completion Date 8/31/30
Dollars Obligated $899K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Davis, CA, USA
Similar Awards
- This $131,278 Project Grant awarded by the Fogarty International Center (CFDA 93.989 - International Research and Research Training program) will support the University of Global Health Equity (UGHE) in Rwanda to research and implement decentralized breast biopsy services at district hospitals. The goal is to improve early diagnosis and treatment of breast cancer, a leading cause of cancer mortality in low- and middle-income countries like Rwanda. The 5-year project will build UGHE's capacity in...
- This federal Project Grant award for $241,888, provided by the Fogarty International Center (CFDA 93.989 - International Research and Research Training program), aims to build an India-Africa network to support research and control of urban malaria transmission. The key products and services to be delivered include: Substantially increasing the scientific leadership and expertise needed for independent urban malaria epidemiology research, strengthening the capabilities and career development...
- The Project Grant award of $300,000.00 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) will support a study on the epidemiology of the gut-liver axis and its relationship to hepatocellular carcinoma (HCC) risk in a multiethnic liver cirrhosis cohort. The study aims to expand the existing Microbiome, Microbial Markers, and Liver Disease (M3LD) cohort by enrolling approximately 1,000 participants with liver cirrhosis, with a focus on...
- This $580,238 federal Project Grant was awarded by the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) to the Regents of the University of Minnesota on January 10, 2025. The grant will fund a 5-year research project to investigate novel blood biomarkers that could predict the early development of hepatocellular carcinoma (liver cancer) in Hispanic individuals infected with the hepatitis B virus. The research aims to develop a non-visual screening approach...
- This Project Grant award of $344,203 from the U.S. Department of Health and Human Services' Fogarty International Center (CFDA 93.989 - International Research and Research Training) supports research to develop effective, resource-appropriate diagnostic tools for aggressive B-cell lymphomas in people with HIV in Malawi. The project, awarded to the University of North Carolina at Chapel Hill, leverages the institution's ongoing clinical, research, and training programs to perform advanced...
- This Project Grant award from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $1,231,538.00 to the Dana-Farber Cancer Institute, Inc. (DFCI) to conduct research on genetic testing, counseling, and management of cancer in Africa. The award period runs from July 1, 2024 to June 30, 2027. The project involves conducting cancer genetic testing and counseling initiatives in Rwanda, with a focus on building local capacity and integrating...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support research to characterize metabolic profiles and outcomes among tuberculosis (TB) patients in Tanzania. The $201,549 award to the Medical University of South Carolina will fund a 5-year study with the following objectives: Measure and describe metabolic markers and TB severity at the time of TB diagnosis, testing...
- This Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides $634,061 to the University of Maryland, Baltimore to study the role of tumor-associated plasmacytoid dendritic cells (TAPDC) in the tumor immune microenvironment (TIME) of liver cancer or hepatocellular carcinoma (HCC) during HIV infection. The 5-year project aims to: 1) Characterize how TAPDC reprogram the HCC TIME in HCC-HIV mouse models and human samples; 2) Define how TAPDC modulate...
- This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $1,292,000.00 to the University of California, San Francisco (UCSF) to conduct in vivo mechanistic characterization of the angiogenic immune checkpoint in liver cancer. The research aims to transform healthcare for Service Members and the American public through innovative and impactful biomedical investigations. The 4-year research project will involve...
- This $584,828 federal Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports the "HEROIC PROSTATE CANCER PRECISION HEALTH (PCAPH) AFRICA1K: POWERING PRECISION HEALTH TO IMPROVE PROSTATE CANCER OUTCOMES IN AFRICA" initiative. The grant, awarded to the University of Nairobi, a prominent Kenyan research university, aims to conduct advanced biomedical research and capacity-building focused on improving...